Take a closer look at recent Coding Clinic information on coding COVID-19, including ICD-10-CM coding for COVID-19 antibody testing, virus signs and symptoms, and comorbidities.
In response to the novel coronavirus (COVID-19) public health emergency, CMS has expanded patient access to telehealth services, allowing beneficiaries to receive a wide range of services without having to visit a healthcare facility.
The AMA on August 10 announced four new CPT® codes for reporting COVID-19 laboratory testing, including two codes for reporting severe acute respiratory syndrome coronavirus 2 antibody detection.
Staying on top of coding guidelines for infectious diseases has never been more critical—or challenging. Review these questions on ICD-10-CM/PCS documentation and coding for infectious diseases including COVID-19, HIV, and related procedures.
CMS released the calendar year (CY) 2021 Medicare Physician Fee Schedule (MPFS) on August 3, introducing 39 new CPT codes, mainly for cardiovascular services. If finalized, the new codes will go into effect January 1, 2021.
Facing the unprecedented COVID-19 public health emergency, CMS released the 2021 OPPS proposed rule later than ever before, with the agency generally reinforcing its recent focus on site-neutral payment policies, lowering reimbursement for drugs purchased under the 340B program, and adding more services to the list of prior authorization.
CMS on July 24 released Transmittal 10230 to inform Medicare contractors of five new Clinical Laboratory Improvement Amendments (CLIA) waived tests approved by the Food and Drug Administration.
Physicians and facilities use the same codes to report E/M levels for ED services, but follow different rules. Outpatient coders must be able to assign E/M codes for both physicians’ work and resources utilized by the facility during emergency visits.
CMS released the 2021ICD-10-CM Official Guidelines for Coding and Reporting on July 8, several weeks earlier than usual. The coding guidelines, which take effect October 1, include new instructions for reporting manifestations of the novel coronavirus (COVID-19), among other changes.
